Grifols Sa Adr Stock Cash And Equivalents
| GRFS Stock | USD 8.54 0.06 0.70% |
Grifols SA ADR fundamentals help investors to digest information that contributes to Grifols SA's financial success or failures. It also enables traders to predict the movement of Grifols Stock. The fundamental analysis module provides a way to measure Grifols SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grifols SA stock.
Grifols |
Grifols SA ADR Company Cash And Equivalents Analysis
Grifols SA's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Grifols SA Cash And Equivalents | 549.09 M |
Most of Grifols SA's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Grifols SA ADR has 549.09 M in Cash And Equivalents. This is 33.11% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 79.68% higher than that of the company.
Grifols Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grifols SA's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Grifols SA could also be used in its relative valuation, which is a method of valuing Grifols SA by comparing valuation metrics of similar companies.Grifols SA is currently under evaluation in cash and equivalents category among its peers.
Grifols Fundamentals
| Return On Equity | 0.0271 | ||||
| Return On Asset | 0.0287 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 15.81 B | ||||
| Shares Outstanding | 257.44 M | ||||
| Shares Owned By Institutions | 58.25 % | ||||
| Number Of Shares Shorted | 4.17 M | ||||
| Price To Earning | 14.34 X | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 0.98 X | ||||
| Revenue | 6.59 B | ||||
| Gross Profit | 2.23 B | ||||
| EBITDA | 1.18 B | ||||
| Net Income | 59.31 M | ||||
| Cash And Equivalents | 549.09 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 10.12 B | ||||
| Debt To Equity | 1.14 % | ||||
| Current Ratio | 2.68 X | ||||
| Book Value Per Share | 7.87 X | ||||
| Cash Flow From Operations | 208.28 M | ||||
| Short Ratio | 7.07 X | ||||
| Earnings Per Share | 0.26 X | ||||
| Price To Earnings To Growth | 0.23 X | ||||
| Target Price | 10.67 | ||||
| Number Of Employees | 23 K | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 7.13 B | ||||
| Total Asset | 21.44 B | ||||
| Retained Earnings | 59.31 M | ||||
| Working Capital | 4.14 B | ||||
| Current Asset | 3.09 B | ||||
| Current Liabilities | 1.05 B | ||||
| Five Year Return | 2.33 % | ||||
| Net Asset | 21.44 B |
About Grifols SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grifols SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grifols SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grifols SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Grifols Stock Analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.